Rockefeller Capital Management’s Q32 Bio QTTB Stock Holding History

Rockefeller Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.7K	Hold	577	–	–	﹤0.01%	4300
2025 Q4	$1.92K	Hold	577	–	–	﹤0.01%	4334
2025 Q3	$1.14K	Buy	+577	New	+$1.11K	﹤0.01%	4172
2023 Q2	–	Sell	-559	Closed	-$10K	–	2048
2023 Q1	$10K	Hold	559	–	–	﹤0.01%	1955
2022 Q4	$12K	Hold	559	–	–	﹤0.01%	3022
2022 Q3	$16K	Sell	559 -11	-2%	-$449	﹤0.01%	2884
2022 Q2	$20K	Buy	570 +11	+2%	+$376	﹤0.01%	2759
2022 Q1	$30K	Hold	559	–	–	﹤0.01%	2553
2021 Q4	$36K	Hold	559	–	–	﹤0.01%	2360
2021 Q3	$79K	Hold	559	–	–	﹤0.01%	1965
2021 Q2	$73K	Hold	559	–	–	﹤0.01%	1923
2021 Q1	$94K	Hold	559	–	–	﹤0.01%	1626
2020 Q4	$113K	Buy	559 +556	+18,533%	+$107K	﹤0.01%	1394
2020 Q3	$0	Hold	3	–	–	﹤0.01%	2837
2020 Q2	$1K	Buy	+3	New	+$800	﹤0.01%	2520
2020 Q1	–	Sell	-10	Closed	-$4K	–	2506
2019 Q4	$4K	Hold	10	–	–	﹤0.01%	1840
2019 Q3	$3K	Hold	10	–	–	﹤0.01%	1755
2019 Q2	$3K	Hold	10	–	–	﹤0.01%	1523
2019 Q1	$5K	Buy	+10	New	+$4.47K	﹤0.01%	1642

Other funds holding QTTB

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Rockefeller Capital Management's QTTB Position: Q1 2026 in Review

Rockefeller Capital Management held its Q32 Bio (QTTB) position steady in Q1 2026 at 577 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4300.

Rockefeller Capital Management first reported a position in QTTB in Q1 2019 and has held it in 19 quarters since. The position peaked at $113K in Q4 2020. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

Rockefeller Capital Management held 577 shares of Q32 Bio worth $3.7K as of Q1 2026.
Rockefeller Capital Management left its Q32 Bio share count unchanged in Q1 2026.
Q32 Bio made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q1 2026, its #4300 holding.
Rockefeller Capital Management first reported a position in Q32 Bio in Q1 2019 and has held it in 19 quarters since.
Rockefeller Capital Management's Q32 Bio position peaked at $113K in Q4 2020.
54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.